Cairo – Mubasher: Alexandria Pharmaceuticals and Chemical Industries reported on Sunday a fall of 15.12% in the company’s profits for the second quarter of the fiscal year 2016-2017 to EGP 15.21 million, versus EGP 17.92 million for Q2-15/16.

Profits for the first half of fiscal 2016/17, however, rose to EGP 36.23 million from EGP 34.07 million for the first half of fiscal 2015/16.

Revenues increased in the first half of fiscal 2016/17 by 17.1% to EGP 262.8 million, compared to EGP 224.5 million for the first half of fiscal 2015/16, according to a bourse statement.

The company said that the floatation of the Egyptian pound led to a loss of EGP 8.15 million.